News from access pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 30, 2014, 08:30 ET

Access Pharmaceuticals Featured On OncLive.com

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced that its novel product for oral...

Jul 22, 2014, 08:30 ET

Access Pharmaceuticals Receives 510(K) FDA Marketing Clearance For ProctiGard™

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a developer of new products for oncology supportive care, announced today that it has received...

Jul 08, 2014, 10:56 ET

Access Pharmaceuticals Awarded Hong Kong Patent For MuGard

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the Hong Kong Patent Office that...

May 01, 2014, 08:30 ET

Access Pharmaceuticals MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that the data from its multi-institutional post-approval trial of MuGard® that was...

Apr 15, 2014, 08:30 ET

Positive Results Of MuGard Study In Erosive Oral Lichen Planus Presented At International Oral Medicine Meeting

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biotechnology company, announced today that positive results from a study conducted at...

Apr 08, 2014, 08:30 ET

Access Pharmaceuticals Provides Update On Development Of LexaGard, A Proprietary Formulation Of Amlexanox

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided an update on a new formulation of the anti-inflammatory drug amlexanox, called...

Apr 01, 2014, 08:16 ET

Access Pharmaceuticals Provides Strategic Update On Mucoadhesive Polymer Hydrogel Technology

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) provided investors with a strategic update on its programs and plans for its proprietary...

Mar 26, 2014, 08:14 ET

Access Pharmaceuticals Cobraxane™ Offers Enhanced Tumor Growth Inhibition In Tumor Models

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biotechnology company, announced today that it is leveraging its proprietary...

Mar 21, 2014, 08:30 ET

Access Pharmaceuticals Advances Development of ProctiGard™ for Radiation Proctitis

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard™, for...

Mar 11, 2014, 08:52 ET

Access Pharmaceuticals Announces MuGard License Agreement With Hanmi Pharmaceutical In Korea

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) today announced that it had entered into an exclusive license agreement with HANMI PHARMACEUTICAL...

Feb 18, 2014, 08:30 ET

Access Pharmaceuticals Announces Publication Of MuGard Clinical Data In Cancer Journal

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced the online early publication of the final results of its post-approval marketing study of...

Sep 24, 2013, 10:42 ET

Access Pharmaceuticals Announces MuGard Poster Presentation At ASTRO Conference

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced a poster presentation at the American Society for...

Sep 12, 2013, 08:30 ET

Access Pharmaceuticals Awarded Second European Patent for MuGard

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, has received notification from the European Patent Office...

Jul 26, 2013, 11:00 ET

Access Pharmaceuticals To Host Investor Call On Wednesday, July 31, 2013

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, will host an investor call to update investors on recent...

Jun 27, 2013, 08:00 ET

Access Pharmaceuticals Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium

ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Dr. Ron R. Allison of Carolina Radiation...

Jun 10, 2013, 08:00 ET

Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, today announced that it had entered into an exclusive...

May 16, 2013, 08:30 ET

Access Pharmaceuticals Reports First Quarter Results

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, released its first quarter ended March 31, 2013 financial...

Apr 29, 2013, 08:30 ET

Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Carrie Daly, MS, RN, APN, AOCN of Rush...

Mar 20, 2013, 08:30 ET

Access Pharmaceuticals To Host Fourth Quarter And Fiscal Year Investor Call On Wednesday, April 3rd At 11:00am ET

 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, will host an investor call to update investors on...

Nov 15, 2012, 08:30 ET

Access Pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th

ACCESS PHARMACEUTICALS, INC.(OTCBB: ACCP), an emerging biopharmaceutical company, will host an investor call to update investors on MuGard...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge